+76.7%
GSK vs RMD
+276.6%
-199.9%
-37.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 2016-09-10 to 2026-09-10.
| Period | Portfolio | RMD | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.0% | -0.2% | -0.9% | -1.0% |
| 7D | -5.4% | -4.2% | -1.2% | -4.6% |
| 30D | -4.6% | -2.1% | -2.5% | -4.2% |
| 3M | -5.1% | +13.8% | -18.9% | -7.9% |
| 6M | -11.4% | -10.6% | -0.8% | -9.8% |
| YTD | +0.7% | -8.1% | +8.8% | +2.0% |
| 1Y | +23.0% | -18.0% | +41.0% | +27.3% |
| 3Y | +48.0% | +52.9% | -4.9% | +32.6% |
| 5Y | +48.2% | -22.3% | +70.5% | +51.3% |
| All | +76.7% | +276.6% | -199.9% | +36.8% |
Cumulative growth
Daily Returns
Daily percentage return beside RMD.
Daily Out/Under-Performance
Portfolio return minus RMD return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × RMD return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 2016-09-10 to 2026-09-10: compounded portfolio wealth divided by compounded RMD wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
2016-09-10 to 2026-09-10 analysis · Full analysis span regression · 6 months rolling